These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 29151197

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Men's Sexual Experiences with the Dapivirine Vaginal Ring in Malawi, South Africa, Uganda and Zimbabwe.
    Montgomery ET, Katz AWK, Duby Z, Mansoor LE, Morar NS, Naidoo K, Tsidya M, Chitukuta M, Guma V, Tenza S, Leslie J, Garcia M, Naidoo S.
    AIDS Behav; 2021 Jun; 25(6):1890-1900. PubMed ID: 33389318
    [Abstract] [Full Text] [Related]

  • 3. Relationship Type and Use of the Vaginal Ring for HIV-1 Prevention in the MTN 020/ASPIRE Trial.
    Pleasants E, Tauya T, Reddy K, Mirembe BG, Woeber K, Palanee-Phillips T, Zimba C, Atujuna M, Montgomery ET, MTN-020/ASPIRE Study Team.
    AIDS Behav; 2020 Mar; 24(3):866-880. PubMed ID: 31111297
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Self-reported removal and expulsion of the dapivirine vaginal ring: qualitative reports from female ring users and their male partners in the Ring Study (IPM 027).
    Milford C, Ramlal H, Mofokeng R, Rambally Greener L, Nel A, Smit J, Malherbe M.
    BMC Public Health; 2024 May 31; 24(1):1458. PubMed ID: 38822304
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Depression Among Pregnant and Breastfeeding Persons Participating in Two Randomized Trials of the Dapivirine Vaginal Ring and Oral Pre-Exposure Prophylaxis (PrEP) in Malawi, South Africa, Uganda, and Zimbabwe.
    Stoner MCD, Mathebula F, Sedze N, Seyama L, Mohuba R, Fabiano Z, Etima J, Young A, Scheckter R, van der Straten A, Piper J, Noguchi L, Montgomery ET, Balán IC.
    AIDS Behav; 2024 Jul 31; 28(7):2264-2275. PubMed ID: 38526641
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Impact of Male Partner Involvement on Women's Adherence to the Dapivirine Vaginal Ring During a Phase III HIV Prevention Trial.
    Roberts ST, Nair G, Baeten JM, Palanee-Philips T, Schwartz K, Reddy K, Kabwigu S, Matovu Kiweewa F, Govender V, Gaffoor Z, Singh N, Siva S, Naidoo K, Montgomery ET, for the MTN-020/ASPIRE Team.
    AIDS Behav; 2020 May 31; 24(5):1432-1442. PubMed ID: 31667678
    [Abstract] [Full Text] [Related]

  • 10. Vaginal Ring Use in a Phase 3 Microbicide Trial: A Comparison of Objective Measures and Self-reports of Non-adherence in ASPIRE.
    Mensch BS, Richardson BA, Husnik M, Brown ER, Kiweewa FM, Mayo AJ, Baeten JM, Palanee-Phillips T, van der Straten A, MTN-020/ASPIRE study team.
    AIDS Behav; 2019 Feb 31; 23(2):504-512. PubMed ID: 30218318
    [Abstract] [Full Text] [Related]

  • 11. Acceptability and use of a dapivirine vaginal ring in a phase III trial.
    Montgomery ET, van der Straten A, Chitukuta M, Reddy K, Woeber K, Atujuna M, Bekker LG, Etima J, Nakyanzi T, Mayo AJ, Katz A, Laborde N, Grossman CI, Soto-Torres L, Palanee-Phillips T, Baeten JM, MTN-020/ASPIRE Study.
    AIDS; 2017 May 15; 31(8):1159-1167. PubMed ID: 28441175
    [Abstract] [Full Text] [Related]

  • 12. Experiences with simultaneous use of contraception and the vaginal ring for HIV prevention in sub-Saharan Africa.
    Leslie J, Kiweewa F, Palanee-Phillips T, Bunge K, Mhlanga F, Kamira B, Baeten J, Katz A, Hillier S, Montgomery E, MTN-020/ASPIRE Study Team.
    BMC Womens Health; 2021 Apr 23; 21(1):175. PubMed ID: 33892693
    [Abstract] [Full Text] [Related]

  • 13. Hygiene, Blood Flow, and Vaginal Overload: Why Women Removed an HIV Prevention Vaginal Ring During Menstruation in Malawi, South Africa, Uganda and Zimbabwe.
    Duby Z, Katz AWK, Browne EN, Mutero P, Etima J, Zimba CC, Woeber K, Atujuna M, Reddy K, van der Straten A, MTN-020/ASPIRE Study Team.
    AIDS Behav; 2020 Feb 23; 24(2):617-628. PubMed ID: 31030301
    [Abstract] [Full Text] [Related]

  • 14. Safety, Acceptability and Adherence of Dapivirine Vaginal Ring in a Microbicide Clinical Trial Conducted in Multiple Countries in Sub-Saharan Africa.
    Nel A, Bekker LG, Bukusi E, Hellstrӧm E, Kotze P, Louw C, Martinson F, Masenga G, Montgomery E, Ndaba N, van der Straten A, van Niekerk N, Woodsong C.
    PLoS One; 2016 Feb 23; 11(3):e0147743. PubMed ID: 26963505
    [Abstract] [Full Text] [Related]

  • 15. Acceptability of the dapivirine vaginal ring for HIV-1 prevention among women reporting engagement in transactional sex.
    Browne EN, Torjesen K, Mirembe BG, Palanee-Phillips T, Jeenarain N, Chitukuta M, Stoner MCD, Mansoor LE, Reddy K, Tauya TT, Naidoo L, Siva S, Richardson B, Dadabhai S, Seyama L, Soto-Torres L, van der Straten A, MTN-020/ASPIRE Study TeamUniversity of California San Francisco, San Francisco, CA, USA.ASTRA Consulting, Kensington, PA, USA..
    AIDS Care; 2024 Jan 23; 36(1):80-86. PubMed ID: 37066990
    [Abstract] [Full Text] [Related]

  • 16. Impact of Women's Home Environment on Use of the Dapivirine Vaginal Ring for HIV Prevention in Sub-Saharan Africa.
    Gichane MW, Katz AWK, Ngure K, Scheckter R, Woeber K, Reddy K, Tauya T, Zimba C, Etima J, Mangxilana N, Palanee-Phillips T, van der Straten A, MTN-025/HOPE Study Team.
    AIDS Behav; 2021 Dec 23; 25(12):3847-3857. PubMed ID: 34009480
    [Abstract] [Full Text] [Related]

  • 17. Negative rumours about a vaginal ring for HIV-1 prevention in sub-Saharan Africa.
    Chitukuta M, Duby Z, Katz A, Nakyanzi T, Reddy K, Palanee-Phillips T, Tembo T, Etima J, Musara P, Mgodi NM, van der Straten A, MTN-020/ASPIRE Study Team.
    Cult Health Sex; 2019 Nov 23; 21(11):1209-1224. PubMed ID: 30657023
    [Abstract] [Full Text] [Related]

  • 18. Does the Ring Work? Perceptions and Understanding of the Efficacy of a Dapivirine Vaginal Ring for HIV Prevention Amongst Women in a Placebo-Controlled Trial.
    Etima J, Katz AWK, Duby Z, Garcia M, Palanee-Phillips T, Reddy K, Mathebula F, Zimba C, Mansoor LE, Singh D, Manengamambo E, Naidoo S, Soto-Torres L, Montgomery ET, MTN-020/ASPIRE, MTN 025/HOPE, MTN-032 Study teams.
    AIDS Behav; 2022 May 23; 26(5):1597-1606. PubMed ID: 34727272
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.